Hyperactivation of RAS or BRAF of the MAPK signalling cascade is the most common oncogenic event in CRC tumorigenesis; it can be hyperactivated via several mechanisms, including mutations [10]. This evidence concerns the gene BRAF and colorectal carcinoma.